Investigational Drug Information for Paltusotine
✉ Email this page to a colleague
What is the drug development status for Paltusotine?
Paltusotine is an investigational drug.
There have been 6 clinical trials for Paltusotine.
The most recent clinical trial was a Phase 2 trial, which was initiated on December 17th 2021.
The most common disease conditions in clinical trials are Acromegaly, Pancreatic Neoplasms, and Neoplasms. The leading clinical trial sponsors are Crinetics Pharmaceuticals Inc. and [disabled in preview].
There are two US patents protecting this investigational drug and twenty-eight international patents.
Summary for Paltusotine
| US Patents | 2 |
| International Patents | 28 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 6 |
| Japanese Patent Applications | 1 |
| Clinical Trial Progress | Phase 2 (2021-12-17) |
| Vendors | 23 |
Recent Clinical Trials for Paltusotine
| Title | Sponsor | Phase |
|---|---|---|
| Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome | Crinetics Pharmaceuticals Inc. | Phase 2 |
| A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2) | Crinetics Pharmaceuticals Inc. | Phase 3 |
| A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly | Crinetics Pharmaceuticals Inc. | Phase 3 |
Clinical Trial Summary for Paltusotine
Top disease conditions for Paltusotine
Top clinical trial sponsors for Paltusotine
US Patents for Paltusotine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Paltusotine | ⤷ Sign Up | Somatostatin modulators and uses thereof | CRINETICS PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Sign Up |
| Paltusotine | ⤷ Sign Up | Somatostatin modulators and uses thereof | CRINETICS PHARMACEUTICALS, INC. (San Diego, CA) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Paltusotine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Paltusotine | Australia | AU2017296392 | 2036-07-14 | ⤷ Sign Up |
| Paltusotine | Australia | AU2020277122 | 2036-07-14 | ⤷ Sign Up |
| Paltusotine | Brazil | BR112019000692 | 2036-07-14 | ⤷ Sign Up |
| Paltusotine | Canada | CA3030423 | 2036-07-14 | ⤷ Sign Up |
| Paltusotine | China | CN109715612 | 2036-07-14 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
